La tétracycline, connue sous le nom commercial Sumycin, agit en bloquant la fixation de l’ARNt sur la sous-unité 30S ribosomale, interrompant l’élongation de la chaîne protéique bactérienne. Ce mécanisme confère une activité sur un spectre large, incluant bactéries Gram positives, Gram négatives, rickettsies et spirochètes. Sa biodisponibilité digestive varie selon la prise alimentaire et les interactions avec les ions divalents comme calcium et magnésium. Sa diffusion tissulaire est importante, notamment dans les voies respiratoires et génito-urinaires. L’élimination se fait par voie rénale et biliaire. Les effets indésirables incluent photosensibilisation, troubles digestifs et coloration dentaire en cas d’administration précoce. Les guides thérapeutiques mentionnent sumycin prix, en soulignant la nécessité de restreindre son utilisation afin de limiter les résistances acquises.
Microsoft word - 4d8ca928-2ba7-28f9bb.doc
TRISOMY 21 RESEARCH FOUNDATION RECOMMENDED PROTOCOL FOR DOWN SYNDROME Trisomy 21 Research recommends the following products as nutrition and/or drug therapy for infants, children, and adults with Down Syndrome.
NuTriVene-D1 or NuTriVene-AD (Adult Formula) Complete Program
-includes Daily Supplement, Daily Enzyme, and NightTime Formula
Vitamin D DHA/EPA Ginkgo Biloba Nutrivene LongvidaTM2 Curcumin Probiotic Piracetam* and/or Cholinesterase Inhibitor Drug* Aricept3 or N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
EXAMPLE SCHEDULE - 3X/DAY
Daily Supplement, Daily Enzyme, Vitamin D, DHA/EPA, Ginkgo Biloba, Probiotic, Piracetam and/or C.I. Drug or NMDA Drug
Afternoon
Daily Supplement, Daily Enzyme, DHA/EPA, Ginkgo Biloba, Probiotic, Piracetam and/or C.I. Drug or NMDA Drug
NightTime Formula, Curcumin (up to 1 hour before bedtime)
EXAMPLE SCHEDULE - 2X/DAY (ALTERNATIVE)
Daily Supplement, Daily Enzyme, Vitamin D, DHA/EPA, Ginkgo Biloba, Probiotic, Piracetam and/or C.I. Drug or NMDA Drug
Afternoon
Daily Supplement, Daily Enzyme, DHA/EPA, Piracetam and/or C.I. Drug or NMDA Drug
NightTime Formula, Curcumin (up to 1 hour before bedtime)
NuTrivene-D or NuTriVene-AD Products Dosed based upon weight. Follow dosage on bottle labels and in directions for use. Do not use Nutrivene-D Daily Enzyme if gastroesophageal reflux is present. Vitamin D Recommended dosage is 1000 IU for children under 6 and 2000 IU for patients 6 years of age and older, including what is found in the Nutrivene-D Daily Supplement. DHA/EPA Products Choose high quality products that meet or exceed national and international standards for purity and are tested for peroxides, heavy metals, and dioxins by a third party. Ginkgo Biloba: Recommended dosage is 5.5 mg per kilogram of body weight for children over 3 years of age. Curcumin: Recommended dosage is up to 2000 mg for all ages. Probiotic: Follow directions for use from manufacturer. Piracetam*: Recommended dosage is 75 mg per kilogram of body weight. Aricept*: Recommended dosage is 5 mg (up to 10 mg) daily for patients over 13 years of age. Namenda*: Follow dosing as recommended by your medical practitioner. WARNINGS: Omega-3 fatty acids may increase the blood-thinning effects of aspirin or warfarin. While the combination of aspirin and omega-3 fatty acids may actually be helpful under certain circumstances (such as heart disease), they should only be taken together under the guidance and supervision of a healthcare provider. Ginkgo biloba should not be used by individuals undergoing blood thinning therapy, those with bleeding issues, or individuals undergoing surgery Curcumin may enhance the effects of anti-platelet drugs, high doses of non-steroidal anti-inflammatory drugs,and warfarin. Do not take if suffering from a biliary tract obstruction or if taking a steroidal anti-inflammatory like prednisone. *Optional
1Nutrivene is a registered trademark of International Nutrition, Inc.
2Longvida is a trademark of Verdure Sciences, Inc.
3Aricept is a registered trademark of Eisai Co., Ltd.
4Namenda is a registered trademark of Forest Laboratories, Inc.
PATIENT APPLICATION FORM General Information Date__________________ How did you hear about our Service? ________________________ Name _________________________________Identity Number _________________________ Home Phone _______________________________Work Phone ________________________ Cell Phone ______________________ Email Address ________________________________ Address _____